Fortress Biotech, Inc.FBIONASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank90
5Y CAGR+15.0%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+15.0%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 72.03% |
| Q2 2025 | 13.24% |
| Q1 2025 | 1612.13% |
| Q4 2024 | 87.44% |
| Q3 2024 | 18.86% |
| Q2 2024 | -247.21% |
| Q1 2024 | -212.89% |
| Q4 2023 | 111.51% |
| Q3 2023 | 18.28% |
| Q2 2023 | -174.11% |
| Q1 2023 | -67.23% |
| Q4 2022 | -47.69% |
| Q3 2022 | -31.87% |
| Q2 2022 | -25.84% |
| Q1 2022 | -16.90% |
| Q4 2021 | 3.41% |
| Q3 2021 | -14.83% |
| Q2 2021 | 1.52% |
| Q1 2021 | 22.37% |
| Q4 2020 | 6.63% |
| Q3 2020 | 35.79% |
| Q2 2020 | 43.78% |
| Q1 2020 | -2.47% |
| Q4 2019 | -7.84% |
| Q3 2019 | -21.10% |
| Q2 2019 | 59.92% |
| Q1 2019 | 128.27% |
| Q4 2018 | -75.75% |
| Q3 2018 | -14.90% |
| Q2 2018 | -12.25% |
| Q1 2018 | 7.02% |
| Q4 2017 | -20.64% |
| Q3 2017 | -19.83% |
| Q2 2017 | 18.67% |
| Q1 2017 | 51.63% |
| Q4 2016 | 10.68% |
| Q3 2016 | 27.73% |
| Q2 2016 | -18.33% |
| Q1 2016 | -16.26% |
| Q4 2015 | 53.22% |